John Cumming
Directeur/Membre du Conseil chez T2 BIOSYSTEMS, INC.
Fortune : 267 $ au 31/05/2024
Postes actifs de John Cumming
Sociétés | Poste | Début | Fin |
---|---|---|---|
T2 BIOSYSTEMS, INC. | Directeur/Membre du Conseil | 01/07/2014 | - |
Independent Dir/Board Member | 01/07/2014 | - | |
Bentley University | Directeur/Membre du Conseil | 24/01/2011 | - |
Cumming & Associates LLC
Cumming & Associates LLC Miscellaneous Commercial ServicesCommercial Services Cumming & Associates LLC is a private company that provides services related to nutrition and sports. The company is based in Dover, DE. The company offers solutions to activate the environment and provide large-scale malevolent ornare. John W. Cumming has been the CEO of the company since 2014. | Directeur Général | 01/07/2014 | - |
Transmed7 LLC
Transmed7 LLC Medical SpecialtiesHealth Technology Transmed7 LLC is a medical and technology-based organization that focuses on developing innovative, minimally-invasive medical devices for doctors and their patients. The private company is based in Phoenix, AZ. The company's portfolio of next-generation platform devices is expected to be market leaders in oncology, regenerative medicine, and cardiovascular disease. Transmed7's business plan and structure enable these new transformational technologies to move from rapid development through commercial manufacturing and market deployment. The company's transformational forward-coring, zero5 biopsy devices improve patient care with broad applications to breast, soft tissue, endoscopy, laparoscopy, robotics, vascular, bone marrow, and more. The company was founded in 2010 by Eugene H. Vetter, James W. Vetter. Eugene H. Vetter has been the CEO since 2010. | Directeur/Membre du Conseil | - | - |
Historique de carrière de John Cumming
Anciens postes connus de John Cumming
Sociétés | Poste | Début | Fin |
---|---|---|---|
HOLOGIC, INC. | Directeur Général | 18/07/2013 | 07/12/2013 |
Président | 01/01/2002 | 01/01/2011 | |
Corporate Officer/Principal | 01/01/2011 | 01/07/2013 | |
President | 01/01/2001 | 01/01/2003 | |
Lorad Corp
Lorad Corp Medical SpecialtiesHealth Technology Lorad Corp manufactured diagnostics products, medical imaging systems and surgical products for women. It provided aptima family of assays, target capture/nucleic acid extraction technology, transcription-mediated amplification technology, hybridization protection and dual kinetic assays. The company was founded on June 11, 1984 and was headquartered in Danbury, CT. | President | - | 01/07/2001 |
Elscint, Inc. | Corporate Officer/Principal | - | - |
HealthCare Markets Group | Fondateur | 25/01/2011 | - |
President | 01/01/1984 | - |
Statistiques
Internationale
Etats-Unis | 9 |
Opérationnelle
President | 3 |
Director/Board Member | 3 |
Corporate Officer/Principal | 2 |
Sectorielle
Health Technology | 5 |
Consumer Services | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
HOLOGIC, INC. | Health Technology |
T2 BIOSYSTEMS, INC. | Health Technology |
Entreprise privées | 5 |
---|---|
HealthCare Markets Group | |
Elscint, Inc. | |
Lorad Corp
Lorad Corp Medical SpecialtiesHealth Technology Lorad Corp manufactured diagnostics products, medical imaging systems and surgical products for women. It provided aptima family of assays, target capture/nucleic acid extraction technology, transcription-mediated amplification technology, hybridization protection and dual kinetic assays. The company was founded on June 11, 1984 and was headquartered in Danbury, CT. | Health Technology |
Cumming & Associates LLC
Cumming & Associates LLC Miscellaneous Commercial ServicesCommercial Services Cumming & Associates LLC is a private company that provides services related to nutrition and sports. The company is based in Dover, DE. The company offers solutions to activate the environment and provide large-scale malevolent ornare. John W. Cumming has been the CEO of the company since 2014. | Commercial Services |
Transmed7 LLC
Transmed7 LLC Medical SpecialtiesHealth Technology Transmed7 LLC is a medical and technology-based organization that focuses on developing innovative, minimally-invasive medical devices for doctors and their patients. The private company is based in Phoenix, AZ. The company's portfolio of next-generation platform devices is expected to be market leaders in oncology, regenerative medicine, and cardiovascular disease. Transmed7's business plan and structure enable these new transformational technologies to move from rapid development through commercial manufacturing and market deployment. The company's transformational forward-coring, zero5 biopsy devices improve patient care with broad applications to breast, soft tissue, endoscopy, laparoscopy, robotics, vascular, bone marrow, and more. The company was founded in 2010 by Eugene H. Vetter, James W. Vetter. Eugene H. Vetter has been the CEO since 2010. | Health Technology |
- Bourse
- Insiders
- John Cumming
- Expérience